Showing results (71-80 of 111) with videos related to
Sort By:
Pageof 12
Cancer Research|February 17, 2017
Myeloid Cells That Impair Immunotherapy Are Restored in Melanomas with Acquired Resistance to BRAF InhibitorsShannon M Steinberg, Tamer B Shabaneh, Peisheng Zhang, et al.Cancer Research|September 19, 2020
CD122-Selective IL2 Complexes Reduce Immunosuppression, Promote Treg Fragility, and Sensitize Tumor Response to PD-L1 BlockadeJustin M Drerup, Yilun Deng, Sri Lakshmi Pandeswara, et al.Oncotarget|June 22, 2016
Tyrosine phosphorylation regulates ERβ ubiquitination, protein turnover, and inhibition of breast cancerBin Yuan, Long Cheng, Kshama Gupta, et al.Experimental Gerontology|February 7, 2018
A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effectsEllen Kraig, Leslie A Linehan, Hanyu Liang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2021
IFNα Augments Clinical Efficacy of Regulatory T-cell Depletion with Denileukin Diftitox in Ovarian CancerSuzanne R Thibodeaux, Brian B Barnett, Srilakshmi Pandeswara, et al.Cancer Medicine|February 24, 2021
Bladder cancer cell-intrinsic PD-L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapyDeyi Zhang, Ryan M Reyes, Erica Osta, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2010
B7-H1-dependent sex-related differences in tumor immunity and immunotherapy responsesPei-Yi Lin, Lishi Sun, Suzanne R Thibodeaux, et al.Cancer Immunology Research|December 20, 2018
Rapamycin Prevents Surgery-Induced Immune Dysfunction in Patients with Bladder CancerRobert S Svatek, Niannian Ji, Essel de Leon, et al.Cancer Research|April 13, 2012
Mitigating age-related immune dysfunction heightens the efficacy of tumor immunotherapy in aged miceVincent Hurez, Benjamin J Daniel, Lishi Sun, et al.Cancer Discovery|October 4, 2016
Tumor Cell-Independent Estrogen Signaling Drives Disease Progression through Mobilization of Myeloid-Derived Suppressor CellsNikolaos Svoronos, Alfredo Perales-Puchalt, Michael J Allegrezza, et al.Pageof 12